Open Access

Table III

Characteristics of the five selected clinical trials.

Author (first) date of publication Study design Country Population characteristics Control groups Inclusion criteria Exclusion criteria Methoxyflurane procedure
Zabolotnii, 2016 Randomized trial Moldova 101 patients (mean age = 29.2 years, 32 F, 69 M) Local anesthesia (41 patients) − Adult (> 18 years)
− Dental caries, pulpal diseases and wedge-shaped defects.
− Kidney or liver deficiencies
− Diabetes
− Pregnancy
− MTXF self-administration using an inhaler in 60 patients
− 10 inhalations before opening the pulp chamber
Allen, 1972 Randomized trial USA 52 patients (17–51 years) (31 F, 21 M) MTXF Cyprane inhaler or MTXF Analgizer − Restorative dentistry
− Oral surgical intervention
− Patient in whom the analgesia was repeated Continuous MTXF analgesia via Cyprane inhaler in 28 patients or Analgizer (closed and open) in 24 patients, from 3 L/min to 12 L/min
Oyama, 1971 Descriptive study Japan 23 patients MTXF Cyprane inhaler or MTXF Analgizer Dental procedures   Increasing MTXF concentrations from 0.2% to 1.1% for 8 min in 10 volunteers and 13 dental out-patients
Goldstein, 1968 Descriptive study USA 50 patients MTXF inhalation using nasal cannula or nasal hood Painful dental manipulation   Increasing concentration of MTXF from 0.1% to reach the desired concentrations:
− using nasal cannula 1% in 20 patients, 1.5% in 5 patients over an interval of 90 s, and after prior 1% MTXF mask inhalation for 60 s before 1% in 10 patients
− using nasal hood 1% in a group of 15 patients
Dragon, 1967 Descriptive study USA 262 patients: 3 groups: 22 children (1–10 years), 83 adolescents (10–15 years) and 157 adults (16–67 years)   − Routine dental operative procedure or simple extraction
− Patient classified as apprehensive
− Patients not classified as apprehensive − First administration by a practitioner and then by a dental assistant using a face mask
− 15 mL of 1% MTXF for 3 min and an additional 2 min in several patients

F: Females, M: Males, MTXF: Methoxyflurane, USA: United States of America.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.